Tomomi Fukuda-Yamamoto - Publications

Menin-MLL inhibitors as a new therapeutic target for middle ear cholesteatoma.

Journal: Scientific reports

Published: October 08, 2025

Effect of histone acetyltransferase inhibitor against middle ear cholesteatoma in mouse model.

Journal: Auris, nasus, larynx

Published: June 20, 2025

Analysis of L1 Cell Adhesion Molecule and Fucosyltransferase 8 Expression in Cells After Stretch and Human EACSCC Tissue.

Journal: The journal of international advanced otology

Published: February 12, 2025

Epigenetic Regulation as a New Therapeutic Target for Middle Ear Cholesteatoma.

Journal: Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology

Published: January 02, 2023

Inhibition of TGF-β signaling enables long-term proliferation of mouse primary epithelial stem/progenitor cells of the tympanic membrane and the middle ear mucosa.

Journal: Scientific reports

Published: July 25, 2022

miR-34a predicts the prognosis of advanced-stage external auditory canal squamous cell carcinoma.

Journal: Acta oto-laryngologica

Published: June 22, 2022

Keratinocyte Growth Factor Stimulates Growth of p75+ Neural Crest Lineage Cells During Middle Ear Cholesteatoma Formation in Mice.

Journal: The American journal of pathology

Published: March 05, 2022

Analysis of the epidermal growth factor receptor/phosphoinositide-dependent protein kinase-1 axis in tumor of the external auditory canal in response to epidermal growth factor stimulation.

Journal: Laryngoscope investigative otolaryngology

Published: December 01, 2021

Super-enhancer Acquisition Drives FOXC2 Expression in Middle Ear Cholesteatoma.

Journal: Journal of the Association for Research in Otolaryngology : JARO

Published: November 09, 2020

Keratinocyte growth factor signaling promotes stem/progenitor cell proliferation under p63 expression during middle ear cholesteatoma formation.

Journal: Current opinion in otolaryngology & head and neck surgery

Published: August 16, 2020

Menin-MLL inhibitor blocks progression of middle ear cholesteatoma in vivo.

Journal: International journal of pediatric otorhinolaryngology

Published: July 05, 2020

L1CAM-ILK-YAP Mechanotransduction Drives Proliferative Activity of Epithelial Cells in Middle Ear Cholesteatoma.

Journal: The American journal of pathology

Published: October 02, 2019